Jennifer Viera | Senior Director, IR & Corporate Communications |
Jay Luly | President, CEO & Director |
Paul Mellett | SVP, Finance & Administration & CFO |
Tara Kieffer | SVP, New Product Strategy & Development |
Douglas Buchanan | JMP Securities |
Brian Skorney | Robert W. Baird & Co. |
Hannah Adeoye | JPMorgan Chase & Co. |
Roanna Ruiz | SVB Securities |
Good afternoon, and welcome to Enanta Pharmaceuticals' Fiscal Third Quarter 2022 Financial Results Conference Call. [Operator Instructions]. Please be advised that this call is being recorded. I would like now to turn the call over to Jennifer Viera, Investor Relations. Please go ahead.